Page last updated: 2024-12-07

thrazarine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

thrazarine: from Streptomyces coerulescens MH802-fF5; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID129042
SCHEMBL ID10421512
MeSH IDM0162032

Synonyms (12)

Synonym
o-((3r)-2-diazo-3-hydroxybutyryl)-l-serine
l-serine, 2-diazo-3-hydroxybutanoate (ester), (r)-
thrazarine
o-(2-diazo-3-hydroxybutyryl)serine
fr900840
2-amino-2-carboxyethyl 2-diazo-3-hydroxybutyrate
fr-900840
120128-14-5
SCHEMBL10421512
o-((r)-2-diazo-3-hydroxybutanoyl)-l-serine
(2s)-2-amino-3-[(3r)-2-diazo-3-hydroxybutanoyl]oxypropanoic acid
AKOS040747539

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]